Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 08/02/20101 min de leitura
Guidance for Industry on the Contents of a Complete Submission for the Evaluation of Proprietary Names; Availability
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Contents of a Complete Submission for the Evaluation of Proprietary Names" (proprietary names submission guidance). This guidance provides recommendations to industry regarding the submission of a complete package that FDA intends to use to assess the safety of proposed proprietary names for drugs, including biological products, and other factors that, in association with the name, can contribute to medication errors. In addition, FDA intends to use this information in the assessment of promotional aspects of proposed proprietary names.
Idioma original da fonte: Federal Register — Health and Human ServicesAbrir o comunicado original →